Covidien plc
Covidien Reports Fourth-Quarter and Fiscal 2009 Results
Published in Health Business Week, December 4th, 2009
Covidien plc (NYSE: COV) reported results for the fourth quarter of fiscal 2009 (July - September 2009). Fourth-quarter net sales of $2.7 billion were essentially unchanged from those of a year ago, with unfavorable foreign exchange of $54 million reducing the quarterly sales growth rate by approximately 2 percentage points. The fourth-quarter results included several one-time items as shown in the attached quarterly Non-GAAP Reconciliations table, including income tax, legal and environmental charges.
Excluding the comparison of $57 million in fourth-quarter 2008 sales of oxycodone hydrochloride extended-release tablets (Oxy ER), fourth-quarter 2009 operational growth...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2009-12-04)
More Articles from Health Business Week
- 1-800-GOT-MOLD?
1-800-GOT-MOLD?'s Dog Detectives Have a Leg Up on the Competition - 3M
3M Introduces Three New Lubricants to Protect Cable During Installation - 4SC AG
4SC Successfully Completes Capital Increase - AARP Idaho
More Idaho Docs Expected To Leave Medicare With 22% Pay Cut Looming - AARP Idaho
Survey Finds AARP Members Back Health Care Reform Legislation - AARP Illinois
Survey Finds Nearly 70 Percent of Illinois AARP Members Back Health Care Reform Legislation - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
